DZIF Antibody Core (Ab-Core) Platform


Description
DZIF-Ab-Core is a central platform for the rapid and comprehensive evaluation of new antibody candidates for the prevention and treatment of infectious diseases. DZIF-Ab-Core provides state-of-the-art technological support for researchers within the DZIF network to effectively address global challenges such as antimicrobial resistance and emerging viruses. Through a secure online interface, members can submit antibody sequences and select from a range of specialized tools and analyses - flexibly and on a need-based basis. Preclinical analyses and antibody production are carried out across sites by experienced partners within DZIF. Services offered by the DZIF-Ab-Core platform: Online interface for structured submission and project planning; Evaluation of antibody sequences (e.g., liability assessment); In vivo analyses for PK determination in relevant models; Structural analyses as well as poly- and autoimmunity reactivity testing; Assessment of manufacturability and mid-scale production; Fc engineering and functional characterization of Fc-mediated effectors.


Type
Data
Subtypes
Database
Focuses
Antibodies

Topics
Data analysis

Contacts

Prof. Dr. Florian Klein
Prof. Dr. Florian Klein

University Hospital Cologne

Coordinator Bridging Topic "Antibody-Based Therapies"

Send mail


Prof. Dr. Stefan Dübel
Prof. Dr. Stefan Dübel

Technische Universität Braunschweig

Send mail


Prof. Dr. Thomas Krey
Prof. Dr. Thomas Krey

Universität zu Lübeck

Send mail




User groups / addressees
Course of study
Scientists

keywords
Analysis data
Antibiotics


Preview image
Preview image
DZIF Bridging Topic "Antibody-Based Therapies"